Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Research & Development (2016 - 2025)

Historic Research & Development for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to $6000.0.

  • ProPhase Labs' Research & Development fell 9508.2% to $6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $173000.0, marking a year-over-year decrease of 7815.66%. This contributed to the annual value of $600000.0 for FY2024, which is 5720.4% down from last year.
  • As of Q3 2025, ProPhase Labs' Research & Development stood at $6000.0, which was down 9508.2% from $4000.0 recorded in Q2 2025.
  • ProPhase Labs' 5-year Research & Development high stood at $572000.0 for Q2 2023, and its period low was $4000.0 during Q2 2025.
  • In the last 5 years, ProPhase Labs' Research & Development had a median value of $115000.0 in 2021 and averaged $175157.9.
  • As far as peak fluctuations go, ProPhase Labs' Research & Development surged by 194285.71% in 2023, and later plummeted by 9714.29% in 2025.
  • Quarter analysis of 5 years shows ProPhase Labs' Research & Development stood at $104000.0 in 2021, then soared by 405.77% to $526000.0 in 2022, then crashed by 50.95% to $258000.0 in 2023, then crashed by 74.42% to $66000.0 in 2024, then plummeted by 90.91% to $6000.0 in 2025.
  • Its last three reported values are $6000.0 in Q3 2025, $4000.0 for Q2 2025, and $97000.0 during Q1 2025.